EU CENTRALIZED DRUG APPROVALS PRODUCE "SIMILAR RESULTS" TO FDA, EMEA's SAUER CLAIMS; ACCOUNTABILITY UNDER MUTUAL RECOGNITION SYSTEM URGED BY JANSSEN EXEC
Executive Summary
The European Union's centralized drug approval system is on par with FDA's prescription drug review process, European Medicines Evaluation Agency Executive Director Fernand Sauer declared at a recent IMS International Conference of Medicines Agencies in the Hague.